Defining the Impact of Surgical Approach on Perioperative Outcomes for Patients with Gastric Cardia Malignancy
Tóm tắt
Gastric cardia cancer is currently treated with several operations. The purpose of the current study was to compare outcomes associated with three common operative approaches. The ACS-NSQIP Participant Use File was searched to identify all patients with gastric cardia malignancy who underwent total gastrectomy (TG), transhiatal esophagectomy (THE), or thoraco-abdominal esophagectomy (TAE) between 2005 and 2012. Demographic, perioperative risk factors, and outcomes were analyzed. Overall, there were 982 patients identified in the database who met inclusion criteria. The median age was 65 years (range 20–88) and 807 (82.2 %) were male. The number of patients allocated to each approach was 204 TGs (20.8 %), 271 THE (27.6 %), and 507 TAE (51.6 %). All approaches had similar major morbidity, cardiopulmonary morbidity, and 30-day mortality, however, TAE was associated with the highest overall morbidity (TAE 49.9 % vs. TG 40.7 % and THE 43.5 %, p = 0.048). The independent risk factors predicting mortality were age greater than 65 years, history of myocardial infarction, and postoperative cardiopulmonary morbidity. For patients with proximal gastric cancer, the three most common operative approaches were associated with clinically-significant rates of overall and major morbidity. Approach-associated morbidity should be considered along with tumor location and extent when choosing a technique for resection of gastric cardia malignancy.
Tài liệu tham khảo
Husemann B. Cardia carcinoma considered as a distinct clinical entity. Br J Surg. 1989;76(2):136–139.
Edge S BD, Compton Cc, Fritz Ag, Green Fl, Trotti A. AJCC Cancer Staging Manual. 2010.
Rice TW, Blackstone EH and Rusch VW. 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann Surg Oncol. 2010;17(7):1721–1724.
Siewert JR, Holscher AH, Becker K and Gossner W. [Cardia cancer: attempt at a therapeutically relevant classification]. Chirurg. 1987;58(1):25–32.
Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.
Blot WJ, Devesa SS, Kneller RW and Fraumeni JF, Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 1991;265(10):1287–1289.
Devesa SS, Blot WJ and Fraumeni JF, Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998;83(10):2049–2053.
Vial M, Grande L and Pera M. Epidemiology of adenocarcinoma of the esophagus, gastric cardia, and upper gastric third. Recent Results Cancer Res. 2010;182:1–17.
Papenfuss WA, Kukar M, Oxenberg J, Attwood K, Nurkin S, Malhotra U and Wilkinson NW. Morbidity and Mortality Associated with Gastrectomy for Gastric Cancer. Ann Surg Oncol. 2014.
Martin JT, Mahan A, Zwischenberger JB, Mcgrath PC and Tzeng CW. Should Gastric Cardia Cancers Be Treated with Esophagectomy or Total Gastrectomy? A Comprehensive Analysis of 4,996 NSQIP/SEER Patients. J Am Coll Surg. 2015;220(4):510–520.
Yang K, Chen HN, Chen XZ, Lu QC, Pan L, Liu J, Dai B, Zhang B, Chen ZX, Chen JP and Hu JK. Transthoracic resection versus non-transthoracic resection for gastroesophageal junction cancer: a meta-analysis. PLoS One. 2012;7(6):e37698.
Ahmed S, Iqbal N, Yadav S, Zaidi A, Ahmed O, Alvi R, Gardner D and Haider K. Time to adjuvant therapy and other variables in localized gastric and gastroesophageal junction (GEJ) cancer (IJGC-D-13-00162). J Gastrointest Cancer. 2014;45(3):284–290.
Lerut T, Moons J, Coosemans W, Van Raemdonck D, De Leyn P, Decaluwe H, Decker G and Nafteux P. Postoperative complications after transthoracic esophagectomy for cancer of the esophagus and gastroesophageal junction are correlated with early cancer recurrence: role of systematic grading of complications using the modified Clavien classification. Ann Surg. 2009;250(5):798–807.
Xia BT, Rosato EL, Chojnacki KA, Crawford AG, Weksler B and Berger AC. Major perioperative morbidity does not affect long-term survival in patients undergoing esophagectomy for cancer of the esophagus or gastroesophageal junction. World J Surg. 2013;37(2):408–415.
Aloia TA, Zimmitti G, Conrad C, Gottumukalla V, Kopetz S and Vauthey JN. Return to intended oncologic treatment (RIOT): a novel metric for evaluating the quality of oncosurgical therapy for malignancy. J Surg Oncol. 2014;110(2):107–114.
Acs. User Guide for the 2012 ACS NSQIP. 2012.
Tzeng CW, Cooper AB, Vauthey JN, Curley SA and Aloia TA. Predictors of morbidity and mortality after hepatectomy in elderly patients: analysis of 7621 NSQIP patients. HPB (Oxford). 2014;16(5):459–468.
Huscher CG, Mingoli A, Sgarzini G, Sansonetti A, Di Paola M, Recher A and Ponzano C. Laparoscopic versus open subtotal gastrectomy for distal gastric cancer: five-year results of a randomized prospective trial. Ann Surg. 2005;241(2):232–237.
Biere SS, Van Berge Henegouwen MI, Maas KW, Bonavina L, Rosman C, Garcia JR, Gisbertz SS, Klinkenbijl JH, Hollmann MW, De Lange ES, Bonjer HJ, Van Der Peet DL and Cuesta MA. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet. 2012;379(9829):1887–1892.
Ito H, Clancy TE, Osteen RT, Swanson RS, Bueno R, Sugarbaker DJ, Ashley SW, Zinner MJ and Whang EE. Adenocarcinoma of the gastric cardia: what is the optimal surgical approach? J Am Coll Surg. 2004;199(6):880–886.
Lerut T, Moons J, Coosemans W, Decaluwe H, Decker G, De Leyn P, Nafteux P and Van Raemdonck D. Multidisciplinary treatment of advanced cancer of the esophagus and gastroesophageal junction: a European center's approach. Surg Oncol Clin N Am. 2008;17(3):485–502, vii-viii.
Meyer HJ. The influence of case load and the extent of resection on the quality of treatment outcome in gastric cancer. Eur J Surg Oncol. 2005;31(6):595–604.
Coupland VH, Lagergren J, Luchtenborg M, Jack RH, Allum W, Holmberg L, Hanna GB, Pearce N and Moller H. Hospital volume, proportion resected and mortality from oesophageal and gastric cancer: a population-based study in England, 2004–2008. Gut. 2013;62(7):961–966.
Anderson O, Ni Z, Moller H, Coupland VH, Davies EA, Allum WH and Hanna GB. Hospital volume and survival in oesophagectomy and gastrectomy for cancer. Eur J Cancer. 2011;47(16):2408–2414.